Bruker BioSciences Corp. (BRKR)

[MSC290]

Bruker CEO buys $10M in company stock

Monday, March 16, 2009 - Boston Business Journal - by Craig M. Douglas

Frank Laukien, the chairman and CEO of life-sciences equipment maker Bruker Corp., has padded his ownership stake in the company to roughly 23 percent, acquiring $10.7 million in Bruker stock between March 5 and March 10.

Laukien, 48, has been CEO of Billerica, Mass.-based Bruker since 1991. His total stake in the company, some 38.2 million shares, is worth just shy of $200 million, based on Monday’s opening trading price of $5.09 a share.

Bruker (Nasdaq: BRKR) makes and distributes equipment and technologies used by drug makers and other product developers in the life sciences sector. The company booked $1.1 in revenue and $64.9 million in net income last year.


http://boston.bizjournals.com/boston/stories/2009/03/16/daily1.html